Appropriateness of liver biopsy

Canadian Journal of Gastroenterology

Volumn 14, Issue 6, 2000, Pages 543-548

  Poynard, Thierry ^a   Ratziu, Vlad ^a   Bedossa, Pierre ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b BICÊTRE HOSPITAL   (France)

Author keywords

Alcoholic liver disease; Hepatitis C; Liver biopsy; Liver biopsy appropriateness

Indexed keywords

ALCOHOL LIVER DISEASE; ALGORITHM; BLEEDING; ECHOGRAPHY; HEPATITIS C; HUMAN; LIVER BIOPSY; MEDICAL LITERATURE; MORTALITY; NEEDLE; PAIN; PERCUTANEOUS BIOPSY; PERITONITIS; PNEUMOTHORAX; PRIORITY JOURNAL; REVIEW;

EID: 0033923418     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2000/107982     Document Type: Review

References (44)

1. Perrillo RP. The role of liver biopsy in hepatitis C. Hepatology 1997;26:57S-61S.
2. Poynard T, Lebrec D. The inconvenience of investigations used in hepatology: patients' and hepatologists' opinions. Liver 1982;2:369-75.
3. von Frerichs. Uber den diabetes. Hirschwald, Berlin: 1884.
4. Schupfer F. De la possibilité de faire 'intra vitam' un diagnostic précis des maladies du foie et de la rate. Semin Med 1907;27:229-30.
5. Huard P. La ponction biopsie du foie et son utilité dans le diagnostic des affections hépatiques. Ann Anat Pathol 1935;12:1118-24.
6. Menghini G. One-second needle biopsy of the liver. Gastroenterology 1958;35:190-9.
7. Theodossi A, Spiegelhalter D, Portmann B, Eddleston AL, Williams R. The value of clinical, biochemical, ultrasound and liver biopsy data in assessing patients with liver disease. Liver 1983;3:315-26.
8. Soloway RD, Baggenstoss AH, Schoenfield LJ, Summerskill WH. Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy. Am J Dig Dis 1971;16:1082-6.
9. Theodossi A, Skene AM, Portmann B, et al. Observer variation in assessment of liver biopsies including analysis by kappa statistics. Gastroenterology 1980;79:232-41.
10. Bedossa P, Poynard T, Naveau S, Martin ED, Agostini H, Chaput JC. Observer variation in assessment of liver biopsies of alcoholic patients. Alcohol Clin Exp Res 1988;12:173-8.
11. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. The French METAVIR Cooperative Study Group. Hepatology 1994;20:15-20.
12. Labayle D, Chaput JC, Albuisson F, Buffet C, Martin E, Etienne JP. [Comparison of the histological lesions in tissue specimens taken from the right and left lobe of the liver in alcoholic liver disease]. Gastroenterol Clin Biol 1979;3:235-40.
13. Pagliaro L, Rinaldi F, Craxi A, et al. Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis. A prospective, randomized trial. Dig Dis Sci 1983;28:39-43.
14. Colombo M, Del Ninno E, de Franchis R, et al. Ultrasound-assisted percutaneous liver biopsy: superiority of the Tru-Cut over the Menghini needle for diagnosis of cirrhosis. Gastroenterology 1988;95:487-9.
15. Papini E, Pacella CM, Rossi Z, et al. A randomized trial of ultrasound-guided anterior subcostal liver biopsy versus the conventional Menghini technique. J Hepatol 1991;13:291-7.
16. Lindor KD, Bru C, Jorgensen RA, et al. The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy. Hepatology 1996;23:1079-83.
17. Maharaj B, Maharaj RJ, Leary WP, et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1986;1:523-5.
18. Crawford AR, Lin XZ, Crawford JM. The normal adult human liver biopsy: a quantitative reference standard. Hepatology 1998;28:323-31.
19. Urena MA, Ruiz-Delgado FC, Gonzalez EM, et al. Assessing risk of the use of livers with macro and microsteatosis in a liver transplant program. Transplant Proc 1998;30:3288-91.
20. Gayral F, Potier M, Salmon R, Labayle D, Larrieu H. [Vascular complications of needle biopsy of the liver]. J Chir (Paris) 1979;116:261-4.
21. Lebrec D, Goldfarb G, Degott C, Rueff B, Benhamou JP. Transvenous liver biopsy: an experience based on 1000 hepatic tissue samplings with this procedure. Gastroenterology 1982;83:338-40.
22. Piccinino F, Sagnelli E, Pasquale G, Giusti G. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 1986;2:165-73.
23. McGill DB, Rakela J, Zinsmeister AR, Ott BJ. A 21-year experience with major hemorrhage after percutaneous liver biopsy. Gastroenterology 1990;99:1396-400.
24. Maharaj B, Bhoora IG. Complications associated with percutaneous needle biopsy of the liver when one, two or three specimens are taken. Postgrad Med J 1992;68:964-7.
25. Van Thiel DH, Gavaler JS, Wright H, Tzakis A. Liver biopsy. Its safety and complications as seen at a liver transplant center. Transplantation 1993;55:1087-90.
26. Janes CH, Lindor KD. Outcome of patients hospitalized for complications after outpatient liver biopsy. Ann Intern Med 1993;118:96-8.
27. Gilmore IT, Burroughs A, Murray-Lyon IM, Williams R, Jenkins D, Hopkins A. Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London. Gut 1995;36:437-41.
28. Vivas S, Palacio MA, Rodriguez M, et al. Ambulatoty liver biopsy: complications and evolution in 264 cases. Rev Esp Enferm Dig 1998;90:175-82.
29. Poynard T, Ramond MJ, Rueff B, Mathurin P, Chaput JC, Benhamou JP. Corticosteroids reduce mortality from alcoholic hepatitis in patients without encephalopathy. A meta-analysis of randomized control trials. Hepatology 1991;14:234A. (Abst)
30. Ramond MJ, Poynard T, Rueff B, et al. A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med 1992;326:507-12.
31. Mathurin P, Duchatelle V, Ramond MJ, et al. Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology 1996;110:1847-53.
32. Talley NJ, Roth A, Woods J, Hench V. Diagnostic value of liver biopsy in alcoholic liver disease. J Clin Gastroenterol 1988;10:647-50.
33. Poynard T, Aubert A, Bedossa P, et al. A simple biological index for detection of alcoholic liver disease in drinkers. Gastroenterology 1991;100:1397-402.
34. Teare JP, Sherman D, Greenfield SM, et al. Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis. Lancet 1993;342:895-8
35. Oberti F, Valsesia E, Pilette C, et al. Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology 1997;113:1609-16.
36. Christensen E, Gludd C. Glucocorticosteroids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables. Gut 1995;37:113-8.
37. Mendenhall CL, Anderson S, Garcia-Pont P, et al. Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone. N Engl J Med 1984;311:1464-70.
38. EASL International Consensus Conference on Hepatitis C. Paris, 26-28, February 1999, Consensus Statement. European Association for the study of the Liver. J Hepatol 1999;30:956-61.
39. Poynard T, Bedossa P. Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups. J Viral Hepat 1997;4:199-208.
40. Bonacini M, Hadi G, Govindarajan S, Lindsay KL. Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1997;92:1302-4.
41. Gaiani S, Gramantieri L, Venturoli N, et al. What is the criterion for differentiating chronic hepatitis from compensated cirrhosis? A prospective study comparing ultrasonography and percutaneous liver biopsy. J Hepatol 1997;27:979-85.
42. Aube C, Oberti F, Korali N, et al. Ultrasonographic diagnosis of hepatic fibrosis or cirrhosis. J Hepatol 1999;30:472-8.
43. Cacoub P, Poynard T, Ghillani P, et al. Extrahepatic manifestations in patients with chronic hepatitis C. Arthritis Rheum 1999;42:2204-12.
44. Mathurin P, Moussalli J, Cadranel JF, et al. Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity. Hepatology 1998;27:868-72.